Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. Sections provide an introduction to leukemia, covering its epidemiology and risk factors, discuss innovative therapies and the use of various nanocarriers, such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels, and discuss precision medicine, AI in leukemia care, and strategies to overcome treatment resistance. The book is enriched with tables, figures, and images, giving healthcare providers, including physicians, immunologists, oncologists, and pharmacists an invaluable resource on cutting-edge therapies.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Dedication - p. v 5. Contents - p. vii 6. Contributors - p. xiii 7. Editors Biography - p. xv 8. Preface - p. xvii 9. Acknowledgments - p. xix 10. Chapter 1 Leukemia and conventional therapy - p. 1 11. Chapter 2 Small interfering RNAs and MicroRNA therapy for leukemia - p. 15 12. Chapter 3 Gene therapy breakthroughs in leukemia treatment and future prospects - p. 27 13. Chapter 4 Polymeric nanoparticles in leukemia management - p. 37 14. Chapter 5 Magnetic nanoparticles in leukemia therapy: Advancements and future directions - p. 49 15. Chapter 6 Mesoporous silica nanoparticles: A novel approach in targeted leukemia therapy - p. 61 16. Chapter 7 Targeted leukemia therapy with solid–lipid nanoparticles: Potential and progress - p. 79 17. Chapter 8 Role of exosomes in leukemia treatment: Advancements in biomarker discovery and drug delivery - p. 93 18. Chapter 9 Nanoemulsion-based drug delivery in leukemia: Potential and progress in therapeutic applications - p. 111 19. Chapter 10 Advances in leukemia treatment using micelles and dendrimers - p. 125 20. Chapter 11 Revolutionizing leukemia therapy with liposomes and niosomes: Targeted delivery and improved efficacy - p. 143 21. Chapter 12 DNA origami nanocarriers: Revolutionizing prostate cancer therapy - p. 159 22. Chapter 13 Leveraging artificial intelligence and machine learning for leukemia cancer management - p. 173 23. Index - p. 185
Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. Sections provide an introduction to leukemia, covering its epidemiology and risk factors, discuss innovative therapies and the use of various nanocarriers, such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels, and discuss precision medicine, AI in leukemia care, and strategies to overcome treatment resistance. The book is enriched with tables, figures, and images, giving healthcare providers, including physicians, immunologists, oncologists, and pharmacists an invaluable resource on cutting-edge therapies.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Dedication - p. v 5. Contents - p. vii 6. Contributors - p. xiii 7. Editors Biography - p. xv 8. Preface - p. xvii 9. Acknowledgments - p. xix 10. Chapter 1 Leukemia and conventional therapy - p. 1 11. Chapter 2 Small interfering RNAs and MicroRNA therapy for leukemia - p. 15 12. Chapter 3 Gene therapy breakthroughs in leukemia treatment and future prospects - p. 27 13. Chapter 4 Polymeric nanoparticles in leukemia management - p. 37 14. Chapter 5 Magnetic nanoparticles in leukemia therapy: Advancements and future directions - p. 49 15. Chapter 6 Mesoporous silica nanoparticles: A novel approach in targeted leukemia therapy - p. 61 16. Chapter 7 Targeted leukemia therapy with solid–lipid nanoparticles: Potential and progress - p. 79 17. Chapter 8 Role of exosomes in leukemia treatment: Advancements in biomarker discovery and drug delivery - p. 93 18. Chapter 9 Nanoemulsion-based drug delivery in leukemia: Potential and progress in therapeutic applications - p. 111 19. Chapter 10 Advances in leukemia treatment using micelles and dendrimers - p. 125 20. Chapter 11 Revolutionizing leukemia therapy with liposomes and niosomes: Targeted delivery and improved efficacy - p. 143 21. Chapter 12 DNA origami nanocarriers: Revolutionizing prostate cancer therapy - p. 159 22. Chapter 13 Leveraging artificial intelligence and machine learning for leukemia cancer management - p. 173 23. Index - p. 185
